Report: China's hospital privatization boosts device, Dx opportunities

Concord Medical Services Holdings has finalized a deal for a 52% stake in China's 1,000-bed Chang'an Hospital, the latest example of China's push to have 20% of its hospital beds privately owned by 2015. As Bloomberg notes, that policy advance, in the context of China's soaring medical services market, will only stand to benefit medical device and diagnostics companies seeking to do business there. The country's medical services market is growing 18% each year and will reach $500 billion by 2015, according to Deloitte China. And the hospital boost, in turn, has increased demand in China for CT and MRI machines, ultrasound and other diagnostic tools and devices, the article notes. Companies, such as GE Healthcare, have already tried to take advantage of the market by opening or planning to open innovation centers in the country. Story

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.